Esketamine's Role in Anesthesia: Emotional Benefits and Cognitive Uncertainty

Esketamine's Emotional Impact in Anesthesia

A recent systematic review and meta-analysis published in June 2026 examined the effects of esketamine on patients undergoing general anesthesia, particularly focusing on emotional and cognitive outcomes. The study, which followed PRISMA guidelines, analyzed 13 randomized controlled trials (RCTs) involving 1,312 patients. Results indicate that esketamine significantly reduces depressive and anxiety symptoms postoperatively, suggesting its potential utility in managing perioperative emotional states.

Mechanisms and Context

Esketamine, a stereoisomer of ketamine, is known for its rapid-acting antidepressant properties. In the context of anesthesia, its administration could alleviate negative emotional states that often accompany surgical procedures. The meta-analysis reported a standardized mean difference (SMD) of -0.92 for depression and -1.23 for anxiety, indicating substantial reductions in these symptoms compared to placebo or standard care.

Policy and Research Implications

The findings from this review could influence clinical protocols, potentially integrating esketamine into perioperative care to improve patient emotional outcomes. However, the study underscores the need for further high-quality research to confirm these benefits and to explore optimal dosing strategies. The review calls for large-scale RCTs to enhance the certainty of evidence and to investigate the cognitive effects of esketamine more thoroughly.

Risks and Unknowns

While the emotional benefits of esketamine are promising, the cognitive outcomes remain uncertain. The meta-analysis revealed high heterogeneity and low evidence certainty regarding cognitive function, with mixed results from cognitive assessments such as the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA). These findings highlight the necessity for caution and further investigation before widespread clinical adoption.

Looking Forward

The potential of esketamine to enhance perioperative care is significant, yet its application must be carefully evaluated through rigorous research. Future studies should aim to clarify its cognitive effects, establish safe and effective dosing regimens, and assess long-term outcomes. As the field of psychedelic research continues to evolve, esketamine's role in anesthesia could represent a pivotal development in improving surgical patient care.